PSMA-MAL-5
PSMA-MAL-5 is a PSMA ligand. PSMA-MAL-5 covalently binds to Cys466 of PSMA. PSMA-MAL-5 labeled with 177Lu and 225Ac has high radiostability and tumor uptake. PSMA-MAL-5 also effectively inhibits tumor growth. PSMA-MAL-5 can be used for SPECT/CT imaging and radionuclide therapy of prostate cancer[1].
Product Specifications
CAS Number
3077205-52-5
UNSPSC
12352005
Target
PSMA
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C([C@@H]1CC[C@H](CC1)CNC([C@H](CCCCNC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)NC(CCCCCN3C(C=CC3=O)=O)=O)=O)N[C@H](C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)CC4=CC=CC5=C4C=CC=C5
Molecular Formula
C65H94N12O20
Molecular Weight
1363.51
References & Citations
[1]Yong W, et al. Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer. J Med Chem. 2025 Aug 28;68 (16) :17794-17807.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
22401126 3x 1.0µg DNA
GOLGB1 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
LV756574 1.0 µg DNA
ZNF602P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details